EN
HI
Aspira Pathlab & Diagnostics Share price
ASPIRA
62
0.90 (-1.43%)Last updated on 18 Aug, 2025 | 15:55 IST
BUYSELL
Today's High
64.16
Today's Low
61.00
52 Week Low
30.00
52 Week High
106.78
The current prices are delayed, login to your account for live prices
LoginAspira Pathlab & Diagnostics Chart
Aspira Pathlab & Diagnostics Share Key Metrics
Volume
306.00
Market Cap
63.82 CR
LTQ@LTP
20@62.00
ATP
61.67
Var Margin
100 %
Circuit Range
59.76-66.04
Delivery %
0 %
Value
18871.02
ASM/GSM
No
Market Lot
1
Aspira Pathlab & Diagnostics Corporate Actions
| Date | Agenda | |
|---|---|---|
| 2025-08-12 | Quarterly Results | |
| 2025-05-16 | Audited Results | |
| Date | Record Date | ||
|---|---|---|---|
 | |||
Aspira Pathlab & Diagnostics News
About Aspira Pathlab & Diagnostics
NSE : 0
BSE : 540788
ISIN : INE500C01017
Aspira Pathlab & Diagnostics Management
| Name | Position |
|---|---|
| Dr. Haseeb Drabu | Chairman & Ind.Director |
| Dr. Pankaj J Shah | Managing Director & CEO |
| Mr. Nikunj Mange | Executive Director |
| Mr. Manas Mengar | Independent Director |
| Mr. Avinash C Mahajan | Independent Director |
Aspira Pathlab & Diagnostics Similar Stocks
Vivo Bio Tech Ltd.
36.71
-0.38 (1.02%)
Roopa Industries Ltd.
52.00
-2.00 (3.70%)
JFL Life Sciences Ltd.
0.00
0.00 (0.00%)
Vista Pharmaceuticals Ltd.
10.51
-0.46 (4.19%)
Shelter Pharma Ltd.
45.80
1.80 (4.09%)
NG Industries Ltd.
148.65
-1.75 (1.16%)
Vineet Laboratories Ltd.
34.60
0.60 (1.76%)
Centenial Surgical Suture Ltd.
155.40
0.00 (0.00%)
Amkay Products Ltd.
53.00
0.00 (0.00%)
Concord Drugs Ltd.
51.00
-1.04 (2.00%)
Aspira Pathlab & Diagnostics FAQs
The Buying Price of Aspira Pathlab & Diagnostics share is 62 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aspira Pathlab & Diagnostics stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aspira Pathlab & Diagnostics, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aspira Pathlab & Diagnostics shares is 26.99. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aspira Pathlab & Diagnostics shares is 0. Useful to assess the stock's value relative to its book value.
To assess Aspira Pathlab & Diagnostics’s valuation compare Sector P/E, P/B which are 57.17 & 3.45 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aspira Pathlab & Diagnostics is 63.82 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aspira Pathlab & Diagnostics share price is 106.78 & 30.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.